Epinephrine autoinjector(Crossject)

N/A

Report date: 2025/12/29 17:43:11

Base Information

Drug NameEpinephrine autoinjector(Crossject)
Drug Alias NameHydrocortisone via ZENEO®CJT-L21
ClassificationSmall molecules > Steroids
Mechanisms of ActionAlpha-1a adrenergic receptor agonistsAlpha adrenergic receptor agonists
TargetsAlpha-1a adrenergic receptorAlpha adrenergic receptor
Therapy Area/IndicationsShock
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrossject
China Registration ClassN/A

Develop Information

Active CompaniesCrossject
Inactive CompaniesN/A
Active IndicationsShock
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A